323 related articles for article (PubMed ID: 19557162)
21. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.
Stenger S; Thüring H; Röllinghoff M; Bogdan C
J Exp Med; 1994 Sep; 180(3):783-93. PubMed ID: 7520472
[TBL] [Abstract][Full Text] [Related]
22. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis.
Fonseca SG; Romão PR; Figueiredo F; Morais RH; Lima HC; Ferreira SH; Cunha FQ
Eur J Immunol; 2003 Aug; 33(8):2297-306. PubMed ID: 12884305
[TBL] [Abstract][Full Text] [Related]
23. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation.
Sato N; Ahuja SK; Quinones M; Kostecki V; Reddick RL; Melby PC; Kuziel WA; Ahuja SS
J Exp Med; 2000 Jul; 192(2):205-18. PubMed ID: 10899907
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
25. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
26. Differential expansion, activation and effector functions of conventional and plasmacytoid dendritic cells in mouse tissues transiently infected with Listeria monocytogenes.
Tam MA; Wick MJ
Cell Microbiol; 2006 Jul; 8(7):1172-87. PubMed ID: 16819969
[TBL] [Abstract][Full Text] [Related]
27. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection.
Iezzi G; Fröhlich A; Ernst B; Ampenberger F; Saeland S; Glaichenhaus N; Kopf M
J Immunol; 2006 Jul; 177(2):1250-6. PubMed ID: 16818784
[TBL] [Abstract][Full Text] [Related]
28. Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection.
Hurdayal R; Nieuwenhuizen NE; Revaz-Breton M; Smith L; Hoving JC; Parihar SP; Reizis B; Brombacher F
PLoS Pathog; 2013 Oct; 9(10):e1003699. PubMed ID: 24204259
[TBL] [Abstract][Full Text] [Related]
29. Requirements for Th1-dependent immunity against infection with Leishmania major.
von Stebut E; Udey MC
Microbes Infect; 2004 Oct; 6(12):1102-9. PubMed ID: 15380780
[TBL] [Abstract][Full Text] [Related]
30. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
31. Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages.
Kuroda S; Nishio M; Sasaki T; Horie Y; Kawahara K; Sasaki M; Natsui M; Matozaki T; Tezuka H; Ohteki T; Förster I; Mak TW; Nakano T; Suzuki A
Eur J Immunol; 2008 May; 38(5):1331-40. PubMed ID: 18398930
[TBL] [Abstract][Full Text] [Related]
32. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major.
Lemos MP; Esquivel F; Scott P; Laufer TM
J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255
[TBL] [Abstract][Full Text] [Related]
33. Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.
Chakour R; Guler R; Bugnon M; Allenbach C; Garcia I; Mauël J; Louis J; Tacchini-Cottier F
Infect Immun; 2003 Sep; 71(9):5287-95. PubMed ID: 12933876
[TBL] [Abstract][Full Text] [Related]
34. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase.
Blos M; Schleicher U; Soares Rocha FJ; Meissner U; Röllinghoff M; Bogdan C
Eur J Immunol; 2003 May; 33(5):1224-34. PubMed ID: 12731047
[TBL] [Abstract][Full Text] [Related]
35. TNF controls the infiltration of dendritic cells into the site of Leishmania major infection.
Ritter U; Lechner A; Scharl K; Kiafard Z; Zwirner J; Körner H
Med Microbiol Immunol; 2008 Mar; 197(1):29-37. PubMed ID: 17661079
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity.
Varikuti S; Verma C; Natarajan G; Oghumu S; Satoskar AR
Am J Pathol; 2021 May; 191(5):809-816. PubMed ID: 33539779
[TBL] [Abstract][Full Text] [Related]
38. IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response.
Chakir H; Campos-Neto A; Mojibian M; Webb JR
Microbes Infect; 2003 Apr; 5(4):241-9. PubMed ID: 12706437
[TBL] [Abstract][Full Text] [Related]
39. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
40. Divergent roles for Ly6C+CCR2+CX3CR1+ inflammatory monocytes during primary or secondary infection of the skin with the intra-phagosomal pathogen Leishmania major.
Romano A; Carneiro MBH; Doria NA; Roma EH; Ribeiro-Gomes FL; Inbar E; Lee SH; Mendez J; Paun A; Sacks DL; Peters NC
PLoS Pathog; 2017 Jun; 13(6):e1006479. PubMed ID: 28666021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
